Bursa Malaysia approves Sapura Energy's PN17 proposed exit plan after four extensions
"The proposed regularisation plan comprises a proposed capital reconstruction, proposed debt restructuring, proposed fund-raising and proposed exemption," Sapura Energy said in a filing with Bursa Malaysia today.
The oil and gas services outfit fell into PN17 status on May 31, 2022 due to its consolidated shareholders' equity of RM85 million being less than 50 per cent of its share capital of RM10.87 billion as of Jan 31, 2022 (FY2022), and a material uncertainty related to going concern highlighted by the company's auditors in its audited financial statements for FY2022.
The company sought its first deadline extension on May 31, 2023, with the latest extension request made on Dec 17, 2024, for a six-month extension until May 31, 2025.
For approval, Sapura Energy and its main adviser for the proposed regularisation plan, MIDF Amanah Investment Bank Bhd, must fully comply with the relevant provisions of the Main Market Listing Requirements regarding the implementation of the proposed plan.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
a day ago
- The Sun
Sapura Energy's regularisation plan to exit P17 status receives Bursa Malaysia approval
PETALING JAYA: Sapura Energy Bhd announced that Bursa Malaysia Securities has, through a letter dated June 30, 2025, approved the company's proposed regularisation plan (PRP). This marks a significant milestone in Sapura Energy's strategic efforts to restructure its debt, strengthen its financial position and exit its status as a company classified under Practice Note 17 (PN17) of the Main Market Listing Requirements. The approved PRP includes a comprehensive suite of measures comprising a capital reconstruction, debt restructuring, fundraising initiative and the necessary regulatory exemptions. These initiatives are designed to address accumulated losses and reduce total borrowings to support Sapura Energy's ongoing business turnaround and set the foundation for future growth. The proposed funding is earmarked for the settlement of outstanding payments to vendors in the Malaysian oil and gas ecosystem. 'We wish to extend our gratitude to Bursa Securities for their approval,' said Sapura Energy group CEO Muhammad Zamri Jusoh. 'This not only validates our regularisation strategy but also paves the way for us to emerge from PN17 stronger and more resilient. We remain committed to executing the regularisation plan responsibly, delivering value to our stakeholders and restoring market confidence in our business.' A general meeting of shareholders will be convened to approve the PRP, after which Sapura Energy will implement the approved measures and achieve full compliance with Bursa Securities' listing requirements. With the restructuring effective date targeted for August 2025 or latest by the longstop date of March 11, 2026, the group is set to conclude one of the most complex restructuring exercises in the country's history.
Malay Mail
a day ago
- Malay Mail
Bursa Malaysia stays marginally higher at midday
KUALA LUMPUR, July 1 — Bursa Malaysia stayed marginally higher at midday, driven by persistent buying activities in selected heavyweights, particularly in the utilities and construction counters, amid mixed sentiment among regional peers. At 12.30pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) edged up 0.65 of-a-point to 1,533.61 from Monday's close of 1,532.96. The benchmark index had opened 1.03 points higher at 1,533.99. The broader market was positive with 394 gainers outnumbering 361 decliners, while 464 counters were unchanged, 1,155 untraded and 13 suspended. Turnover stood at 1.05 billion units worth RM851.71 million. Rakuten Trade Sdn Bhd equity research vice-president Thong Pak Leng said traders are optimistic that the United States will be able to strike trade deals with its partners once its 90-day tariff reprieve ends next week, noting that Wall Street ended broadly higher overnight. 'Back home, the FBM KLCI closed higher at above the 1,530 mark, possibly due to the return of foreign funds,' he said in a note, adding that he expects the index to trend within the 1,530-1,540 range today. Among the heavyweights, Tenaga Nasional rose 24 sen to RM14.62, while Maybank slid 1.0 sen to RM9.69, CIMB and Public Bank both dropped 4.0 sen to RM4.27 and RM6.75, respectively, and IHH Healthcare shed 3.0 sen to RM6.79. As for the most active stocks, Sapura Energy gained half-a-sen to 4.0 sen, MYEG added 1.0 sen to 96 sen, Pharmaniaga expanded 2.5 sen to 16 sen and Gamuda advanced 16 sen to RM4.95, while Tanco reduced 2.0 sen to 89.5 sen. On the index board, the FBM Emas Index climbed 15.92 points to 11,463.69, the FBMT 100 Index garnered 13.71 points to 11,243.47, and the FBM Emas Shariah Index increased 47.45 points to 11,485.69. The FBM 70 Index advanced 59.31 points to 16,458.92, while the FBM ACE Index went down 10.43 points to 4,459.50. By sector, the Financial Services Index fell 59.09 points to 17,591.49 and the Industrial Products and Services Index edged down 0.49 of-a-point to 153.34, while the Plantation Index bagged 10.78 points to 7,360.98, and the Energy Index added 3.45 points to 738.73. — Bernama
New Straits Times
a day ago
- New Straits Times
Pharmaniaga surges on rights issue buzz, trading hits highest in nearly two months
KUALA LUMPUR: Pharmaniaga Bhd soared in heavy trade as investors piled in ahead of a high-stakes rights issue that could reshape the pharmaceutical firm's balance sheet. The counter jumped 22.2 per cent to 16.5 sen by mid-morning, emerging as the second most actively traded stock on Bursa Malaysia, with 17.05 million shares changing hands as at 11.35am. It is Pharmaniaga's busiest trading day in nearly two months, as investors react to the stock's ex-rights pricing. The rally follows the company's move to raise fresh capital through a heavily dilutive rights issue of up to 3.52 billion new shares at 10 sen each, potentially generating up to RM352.15 million in proceeds. The renounceable issue is on the basis of 12 rights shares for every five held, with entitlements fixed at 5pm tomorrow. Rights trading will begin on Thursday, giving shareholders a chance to cash in or double down. Prospectuses and allotment letters are slated for distribution on Friday, while the final day to subscribe or sell the rights is July 17. Pharmaniaga, a Practice Note 17 company, is banking on the fundraising exercise to stabilise its finances after a turbulent year marked by losses and mounting liabilities. At 16.5 sen, Pharmaniaga is valued at about RM237.8 million.
